U.S. may expand Nvidia and AMD’s 15% China chips deal to other companies
Investing.com -- According to Reuters, several drugmakers have reportedly begun accelerating shipments of medicines to the United States in response to potential tariff threats from President Donald Trump. The President is anticipated to announce new tariffs on April 2, which could affect products manufactured in Europe.
Two executives from European-based pharmaceutical companies and representatives from two logistics firms have indicated ro Reuters that an increased volume of medicines is being transported to the U.S. by air. This move is seen as a precautionary measure to circumvent any potential disruptions that the expected tariffs might cause.
The companies, which have not been named, have been actively sending more of their drugs across the Atlantic for the past several weeks. They are utilizing major global cargo and transport services such as United Parcel Service Inc (NYSE:UPS) and Germany’s DHL (ETR:DHL) to facilitate these expedited deliveries.
One of the executives mentioned that their company is engaged in "scenario planning" for the possible imposition of tariffs and has consequently increased the volume of medicines shipped by air.
Additionally, a source from a third international pharmaceutical firm revealed that they are swiftly moving available stock from overseas to the U.S.
This development underscores the pharmaceutical industry’s concern over the impact of trade policies on their operations and the potential for tariffs to affect the supply of medicines in the United States.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.